Ravi Sheshala

Dr. Ravi Sheshala

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Drug Discovery Today
Verified
Journal Article
Open access
VYVenkata Kashyap Yellepeddi
Venkata Kashyap Yellepeddi
RSRavi Sheshala
Ravi Sheshala
HMHannah McMillan
Hannah McMillan
CGChirag Gujral
Chirag Gujral
DJDavid Jones
David Jones
TSThakur Raghu Raj Singh
Thakur Raghu Raj Singh
Punctal plugs (PPs) are miniature medical implants that were initially developed for the treatment of dry eyes. Since their introduction in 1975, many PPs made from different materials and designs have been developed. PPs, albeit generally successful, suffer from drawbacks such as epiphora and suppurative canaliculitis. To overcome these issues intelligent designs of PPs were proposed (e.g. SmartPLUG™ and Form Fit™). PPs are also gaining interest among pharmaceutical scientists for sustaining drug delivery to the eye. This review aims to provide an overview of PPs for dry eye treatment and drug delivery to treat a range of ocular diseases. It also discusses current challenges in using PPs for ocular diseases.

1 February 2018 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
RSRavi Sheshala
Ravi Sheshala
SQSoo Ying Quah
Soo Ying Quah
GTGiok Choo Tan
Giok Choo Tan
VMVenkata Srikanth Meka
Venkata Srikanth Meka
NJNaveen Jnanendrappa
Naveen Jnanendrappa
PSPriyadarshi Soumyaranjan Sahu
Priyadarshi Soumyaranjan Sahu

26 February 2018 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
RSRavi Sheshala
Ravi Sheshala
GHGan Chew Hong
Gan Chew Hong
WYWong Pui Yee
Wong Pui Yee
VMVenkata Srikanth Meka
Venkata Srikanth Meka
TSThakur Raghu Raj Singh
Thakur Raghu Raj Singh

21 December 2022 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
RSRavi Sheshala
Ravi Sheshala
NWNg Zing Wai
Ng Zing Wai
ISIqbal Danial Said
Iqbal Danial Said
KAKAMRAN ASHRAF
KAMRAN ASHRAF
SLSiong Meng Lim
Siong Meng Lim
FZFarrukh Zeeshan
Farrukh Zeeshan
Orthosiphon stamineus Benth. (OS) is a commonly used medicinal plant for curbing bacterial infections globally. This work aimed to fabricate poloxamer and chitosan-based in situ gels loaded with standardized aqueous-ethanolic OS leaf extracts and investigate their antimicrobial efficacy as a potential remedy against ocular infections. In situ gels containing 0.5% w/v OS extract prepared using cold dispersion method were subjected to physicochemical characterization, including in vitro-release studies. Antimicrobial efficacy was tested against Staphylococcus aureus, Micrococcus luteus, Escherichia coli, and Pseudomonas aeruginosa using agar diffusion method. Thin layer chromatography and high performance liquid chromatography chromatograms confirmed the presence of rosmarinic acid (RA) and sinensitin in OS extracts with same retention factor (0.26 and 0.49) and retention times (12.2 and 20.7 min) against reference standards. A homogenous brown coloured in situ gel exhibited low viscosity as a solution and increased viscosity in gel form at ocular temperature. The optimized formulations, P7 (21% P407/4% P188), P8 (21% P407/5% P188) and F5 (1.5% chitosan and 45% β-glycerophosphate) exhibited ideal ocular pH (7.27-7.46), phase transition at ocular temperature (33-37°C) and prolonged RA release up to 12 h. Formulation F5 showed an inhibition zone of 4.3 mm against M. luteus. Among all, formulation F5 alone exhibited modest antimicrobial activity against M. luteus. OS extracts at 5% and 10% were most active against tested bacteria however, loading them into in situ gels resulted in sedimentation. Hence, isolation of RA from OS extract is suggested before loading into formulations for a better antimicrobial activity.

1 September 2019 in Powder Technology
Verified
Journal Article
Closed access
LZLidawati Zakaria
Lidawati Zakaria
TWTin Wui Wong
Tin Wui Wong
NANor Khaizan Anuar
Nor Khaizan Anuar
INIdanawati Naharudin
Idanawati Naharudin
MTMinaketan Tripathy
Minaketan Tripathy
ZHZahid Hussain
Zahid Hussain

1 March 2016 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
VMVenkata Srikanth Meka
Venkata Srikanth Meka
CLChew Ee Li
Chew Ee Li
RSRavi Sheshala
Ravi Sheshala
The aim of this research was to formulate effervescent floating drug delivery systems of theophylline, using different release retarding polymers such as ethyl cellulose, Eudragit® L100, xanthan gum and polyethylene oxide (PEO) N12K. Sodium bicarbonate was used as a gas generating agent. Direct compression was used to formulate floating tablets and the tablets were evaluated for their physicochemical and dissolution characteristics. PEO based formulations produced better drug release properties than other formulations. Hence, it was further optimized by central composite design. Further subjects of research were the effect of formulation variables on floating lag time and the percentage of drug released at the seventh hour (D7h). The optimum quantities of PEO and sodium bicarbonate, which had the highest desirability close to 1.0, were chosen as the statistically optimized formulation. No interaction was found between theophylline and PEO by Fourier Transformation Infrared spectroscopy (FTIR) and Differential Scanning Calorimetry (DSC) studies